
Patrick Keereman
Chairman of the Board
Ensuring the intestinal health of piglets
Animab offers a safe and sustainable way to protect piglets' intestinal health during the vital post-weaning stage. Our proprietary antibodies mimic secretory IgA, a type of natural antibody passed through colostrum and milk to protect nursing animals.
In a collaborative effort with VIB and the Ghent University Faculty of Veterinary Medicine, Animab further improved these antibodies to target with speed and precision specific intestinal pathogens in livestock without altering the healthy microbiome.
Animab will continue to collaborate with these top academic research groups to expand the high precision biological resources available to protect young animals.
Key figures
of piglets affected by post-weaning diarrhea
increase in global demand for pork by 2050
of antimicrobials used for animals
Patrick Keereman
Chairman of the Board
Carla Snoeck
Manager New Ventures
VIB (Vlaams Instituut Biotechnologie)
Kenneth Wills
Head of Life Sciences & Care
PMV (Participatie Maatschappij Vlaanderen)
Laetitia Gerbe
Partner for AVF Fund
Seventure Partners
Patrik Haesen
Senior Investment Manager
Agri Investment Fund
Shelley Margetson
Managing Partner
V-BIO Ventures
Sofie Baeten
Managing Partner
Qbic III
Vikram Virdi
Ann Depicker
Nico Callewaert
Eric Cox
Henri De Greve
Yes, I want to know more about Animab